Peer-reviewedCC BYTouchREVIEWS in endocrinology25 Aug 2026

Type 2 diabetes and the cardio–renal–metabolic syndrome: The evolving roles of GLP-1 and dual GLP-1/GIP receptor agonists

Clipper F Young¹
Namrita George²
Alexander Olson¹
Diana Isaacs³

¹Touro University California College of Osteopathic Medicine, Vallejo, CA, USA
²Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas, NV, USA
³Cleveland Clinic Endocrinology & Metabolism Institute, Cleveland, OH, USA

Economic evaluation of SGLT2 inhibitors and GLP-1 receptor agonists in Thai patients with type 2 diabetes and established atherosclerotic cardiovascular disease
Tanawan Kongmalai, Natthakan Chitpim, Varalak Srinonprasert +2
Scientific Reports6 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textEndocrinology & metabolismCrossref
Multisystem Outcomes of GLP-1 Receptor Agonists Versus Active Comparators in Type 2 Diabetes: A Multicenter Target Trial Emulation
Rohit Vashisht, Sanket S. Dhruva, Ayan Patel +8
Journal of Diabetes Science and Technology28 Oct 2026Peer-reviewedLicence not statedFull textEndocrinology & metabolismPMC
Potential for GLP-1 Receptor Agonists in Irritable Bowel Syndrome
Michael Camilleri, Alexander C. Ford
Gastroenterology23 Oct 2026Peer-reviewedLicence not statedFull textGeneral medicinePMC
Use of SGLT2 Inhibitors, GLP‐1 Receptor Agonists, and DPP‐4 Inhibitors in Incident Hyponatremia in Patients with Type 2 Diabetes: Multicenter Target Trial Emulations
Ying‐Hsuan Lin, Daniel Hsiang‐Te Tsai, Miyuki Hsing‐Chun Hsieh +5
Clinical Pharmacology and Therapeutics26 Oct 2026Peer-reviewedLicence not statedFull textEndocrinology & metabolismPMC
GLP-1 Receptor Agonists and Obesity-Related Cancer by Diabetes Severity
Jesús Gibran Hernández-Pérez, Omer Abdelgadir, Luisa Torres-Sánchez +5
JAMA Network Open3 Nov 2026Peer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossrefPMC

Cite

BibTeX

@article{young2026type,
  title = {{Type 2 diabetes and the cardio–renal–metabolic syndrome: The evolving roles of GLP-1 and dual GLP-1/GIP receptor agonists}},
  author = {Clipper F Young and Namrita George and Alexander Olson and Diana Isaacs},
  journal = {TouchREVIEWS in endocrinology},
  year = {2026},
  month = aug,
  doi = {10.17925/ee.2026.22.2.3},
  url = {https://europepmc.org/article/PMC/PMC13730168},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Type 2 diabetes and the cardio–renal–metabolic syndrome: The evolving roles of GLP-1 and dual GLP-1/GIP receptor agonists
AU  - Clipper F Young
AU  - Namrita George
AU  - Alexander Olson
AU  - Diana Isaacs
PY  - 2026
DA  - 2026/08/25
JO  - TouchREVIEWS in endocrinology
DO  - 10.17925/ee.2026.22.2.3
UR  - https://europepmc.org/article/PMC/PMC13730168
SN  - 2752-5457
ER  -

Related

Cite